[go: up one dir, main page]

NO921839L - Fremgangsmaate for isolering av faktor viii - Google Patents

Fremgangsmaate for isolering av faktor viii

Info

Publication number
NO921839L
NO921839L NO92921839A NO921839A NO921839L NO 921839 L NO921839 L NO 921839L NO 92921839 A NO92921839 A NO 92921839A NO 921839 A NO921839 A NO 921839A NO 921839 L NO921839 L NO 921839L
Authority
NO
Norway
Prior art keywords
factor viii
procedure
insulating factor
proteins
plasma
Prior art date
Application number
NO92921839A
Other languages
English (en)
Other versions
NO180741B (no
NO180741C (no
NO921839D0 (no
Inventor
Per Kaersgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO921839D0 publication Critical patent/NO921839D0/no
Publication of NO921839L publication Critical patent/NO921839L/no
Publication of NO180741B publication Critical patent/NO180741B/no
Publication of NO180741C publication Critical patent/NO180741C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Housing For Livestock And Birds (AREA)
  • Cephalosporin Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Amplifiers (AREA)
  • Networks Using Active Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO921839A 1989-11-09 1992-05-08 Fremgangsmåte for isolering av Faktor VIII NO180741C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
PCT/DK1990/000279 WO1991007438A1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii

Publications (4)

Publication Number Publication Date
NO921839D0 NO921839D0 (no) 1992-05-08
NO921839L true NO921839L (no) 1992-07-08
NO180741B NO180741B (no) 1997-03-03
NO180741C NO180741C (no) 1997-06-11

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921839A NO180741C (no) 1989-11-09 1992-05-08 Fremgangsmåte for isolering av Faktor VIII

Country Status (26)

Country Link
US (1) US5245014A (no)
EP (1) EP0524172B1 (no)
JP (1) JP2509407B2 (no)
CN (1) CN1044121C (no)
AT (1) ATE118508T1 (no)
AU (1) AU631471B2 (no)
BG (1) BG61231B1 (no)
CA (1) CA2073012C (no)
CZ (1) CZ537190A3 (no)
DE (1) DE69017050T2 (no)
DK (1) DK162233C (no)
ES (1) ES2068404T3 (no)
FI (1) FI103510B (no)
HU (1) HU214905B (no)
IE (1) IE66836B1 (no)
IL (1) IL96277A (no)
NO (1) NO180741C (no)
NZ (1) NZ236004A (no)
PL (1) PL164894B1 (no)
PT (1) PT95830B (no)
RU (1) RU2055593C1 (no)
SK (1) SK537190A3 (no)
UA (1) UA29421C2 (no)
WO (1) WO1991007438A1 (no)
YU (1) YU47524B (no)
ZA (1) ZA908599B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0399321T3 (da) * 1989-05-24 1993-08-09 Miles Inc Gelfiltrering af varmebehandlet faktor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
EP2130554B1 (en) 1999-02-22 2012-09-05 University of Connecticut Albumin-free factor VIII formulations
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
CA2437015A1 (en) * 2001-02-05 2002-08-15 Novo Nordisk Health Care Ag Combined use of factor vii polypeptides and factor ix polypeptides
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
RU2253475C1 (ru) * 2004-02-02 2005-06-10 Общество с ограниченной ответственностью "Гемоцентр" Способ получения препарата фактора viii
JP2007536230A (ja) 2004-05-03 2007-12-13 エモリー ユニバーシティ ブタＢドメイン欠損ｆＶＩＩＩの投与方法
CN101010333B (zh) * 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
RU2324495C1 (ru) * 2006-08-31 2008-05-20 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения препарата фактора свертывания viii крови человека
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
RU2731720C2 (ru) * 2010-03-30 2020-09-08 Октафарма Аг Способ очистки витамин к-зависимых белков, таких как коагуляционный фактор vii
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
CA2816575C (en) 2010-11-05 2019-06-11 Baxter Healthcare S.A. A new variant of antihemophilic factor viii having increased specific activity
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
PL2902787T3 (pl) * 2012-09-28 2018-08-31 Chugai Seiyaku Kabushiki Kaisha Sposób oceny reakcji krzepnięcia krwi
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0321835B1 (en) * 1987-12-21 1994-09-28 Miles Inc. Gel filteration of factor VIII
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
DK0399321T3 (da) * 1989-05-24 1993-08-09 Miles Inc Gelfiltrering af varmebehandlet faktor VIII

Also Published As

Publication number Publication date
DE69017050D1 (de) 1995-03-23
AU631471B2 (en) 1992-11-26
PT95830A (pt) 1991-09-30
CA2073012C (en) 1996-03-19
EP0524172A1 (en) 1993-01-27
DK562189D0 (da) 1989-11-09
CN1051732A (zh) 1991-05-29
NO180741B (no) 1997-03-03
HU214905B (hu) 1998-07-28
JP2509407B2 (ja) 1996-06-19
WO1991007438A1 (en) 1991-05-30
IE66836B1 (en) 1996-02-07
IL96277A (en) 1995-07-31
FI922105L (fi) 1992-05-08
HUT60511A (en) 1992-09-28
UA29421C2 (uk) 2000-11-15
CA2073012A1 (en) 1991-05-10
CZ537190A3 (cs) 1998-05-13
DK162233C (da) 1992-03-16
HU9201551D0 (en) 1992-08-28
DE69017050T2 (de) 1995-06-14
FI922105A0 (fi) 1992-05-08
BG61231B1 (en) 1997-03-31
YU210590A (sh) 1993-05-28
FI103510B1 (fi) 1999-07-15
ZA908599B (en) 1991-07-31
US5245014A (en) 1993-09-14
NO180741C (no) 1997-06-11
ES2068404T3 (es) 1995-04-16
DK562189A (da) 1991-05-10
JPH05501557A (ja) 1993-03-25
PL164894B1 (pl) 1994-10-31
EP0524172B1 (en) 1995-02-15
SK278640B6 (en) 1997-12-10
PT95830B (pt) 1997-11-28
ATE118508T1 (de) 1995-03-15
NZ236004A (en) 1991-11-26
RU2055593C1 (ru) 1996-03-10
NO921839D0 (no) 1992-05-08
YU47524B (sh) 1995-10-03
FI103510B (fi) 1999-07-15
PL287703A1 (en) 1991-12-02
IL96277A0 (en) 1991-08-16
DK162233B (da) 1991-09-30
CN1044121C (zh) 1999-07-14
SK537190A3 (en) 1997-12-10
BG96316A (bg) 1993-12-24
IE904022A1 (en) 1991-05-22
AU6747090A (en) 1991-06-13

Similar Documents

Publication Publication Date Title
NO921839L (no) Fremgangsmaate for isolering av faktor viii
AU584576B2 (en) Process for separation of hydrocarbon gases
AU580494B2 (en) Process for the extraction and purification of proteins from culture media producing them
AU584577B2 (en) Process for separation of hydrocarbon gases
NZ218913A (en) Process for separating components of natural gas
AU578554B2 (en) Centrifugal method of separating blood components
DE58900776D1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
FI874504L (fi) Menetelmä hyaluronihapon täydellisesti tai osittain silloitettujen esterien valmistamiseksi
KR880701778A (ko) 펩티드의 합성 및 분리를 위한 효소막법
DE3788229D1 (de) Verfahren zur isolierung von ca 125-antigen.
AU584578B2 (en) Process for separation of hydrocarbon mixtures
AU582497B2 (en) Improved process for separation of acid gases
PT84879B (en) Process for the production of hybrid polypetides from bacterial clones comprising somatocrinine and alpha 1-antitrypsin and process for the production of somatocrinine
EP0256214A3 (en) Process for separation of water-insolouble distillates from water vapour
EP0213814A3 (en) Synthesis of tricyclazole
GB1479512A (en) Dimeric indole alkaloid purification process
AU6385886A (en) Production of ige-binding protein by recombinant methods
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
AU1929188A (en) Process for recovery of gold
IL78130A0 (en) Method of separating or purifying proteins and other biopolymers
DK690587A (da) Tetrapeptid, dets fremstilling og anvendelse
BG44094A1 (en) Method for separating of furfurol from hydrolysate
BR8807543A (pt) Separador de liquidos e processo de separar componentes liquidos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003